Shanghai Pharmaceuticals Holding Co., Ltd S1R.F Stock
Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
Shanghai Pharmaceuticals Holding Co., Ltd S1R.F Financial and Trading Overview
Contents
- Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
- Shanghai Pharmaceuticals Holding Co., Ltd S1R.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Pharmaceuticals Holding Co., Ltd
- Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
Shanghai Pharmaceuticals Holding Co., Ltd stock price | 1.33 EUR |
Previous Close | 1.74 EUR |
Open | 1.74 EUR |
Bid | 1.76 EUR x 150000 |
Ask | 1.82 EUR x 150000 |
Day's Range | 1.74 - 1.76 EUR |
52 Week Range | 1.31 - 1.9 EUR |
Volume | 20 EUR |
Avg. Volume | 20 EUR |
Market Cap | 9.26B EUR |
Beta (5Y Monthly) | 0.320547 |
PE Ratio (TTM) | 8.380953 |
EPS (TTM) | 0.13 EUR |
Forward Dividend & Yield | 0.06 (3.54%) |
Ex-Dividend Date | July 20, 2022 |
1y Target Est | N/A |
S1R.F Valuation Measures
Enterprise Value | 30.37B EUR |
Trailing P/E | 8.380953 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.0383915 |
Price/Book (mrq) | 0.094935 |
Enterprise Value/Revenue | 0.126 |
Enterprise Value/EBITDA | 3.051 |
Trading Information
Shanghai Pharmaceuticals Holding Co., Ltd Stock Price History
Beta (5Y Monthly) | 0.320547 |
52-Week Change | 17.33% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.9 EUR |
52 Week Low | 1.31 EUR |
50-Day Moving Average | 1.79 EUR |
200-Day Moving Average | 1.6 EUR |
S1R.F Share Statistics
Avg. Volume (3 month) | 20 EUR |
Avg. Daily Volume (10-Days) | 2 EUR |
Shares Outstanding | 919.07M |
Float | 1.64B |
Short Ratio | N/A |
% Held by Insiders | 22.00% |
% Held by Institutions | 31.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.61 |
Trailing Annual Dividend Yield | 35.05% |
5 Year Average Dividend Yield | 346.00% |
Payout Ratio | 0.2681 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.43% |
Operating Margin (ttm) | 3.57% |
Gross Margin | 13.12% |
EBITDA Margin | 4.12% |
Management Effectiveness
Return on Assets (ttm) | 2.78% |
Return on Equity (ttm) | 9.61% |
Income Statement
Revenue (ttm) | 241.31B EUR |
Revenue Per Share (ttm) | 65.27 EUR |
Quarterly Revenue Growth (yoy) | 16.40% |
Gross Profit (ttm) | N/A |
EBITDA | 9.96B EUR |
Net Income Avi to Common (ttm) | 5.88B EUR |
Diluted EPS (ttm) | 0.21 |
Quarterly Earnings Growth (yoy) | 21.30% |
Balance Sheet
Total Cash (mrq) | 38.11B EUR |
Total Cash Per Share (mrq) | 10.3 EUR |
Total Debt (mrq) | 50.66B EUR |
Total Debt/Equity (mrq) | 63.42 EUR |
Current Ratio (mrq) | 1.375 |
Book Value Per Share (mrq) | 18.539 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.61B EUR |
Levered Free Cash Flow (ttm) | -1122903680 EUR |
Profile of Shanghai Pharmaceuticals Holding Co., Ltd
Country | Germany |
State | N/A |
City | Shanghai |
Address | Shanghai Pharmaceutical Building |
ZIP | 200020 |
Phone | 86 21 6373 0908 |
Website | https://www.sphchina.com |
Industry | Medical Distribution |
Sector(s) | Healthcare |
Full Time Employees | 47877 |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
What is a current S1R.F stock price?
Shanghai Pharmaceuticals Holding Co., Ltd S1R.F stock price today per share is 1.33 EUR.
How to purchase Shanghai Pharmaceuticals Holding Co., Ltd stock?
You can buy S1R.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Pharmaceuticals Holding Co., Ltd?
The stock symbol or ticker of Shanghai Pharmaceuticals Holding Co., Ltd is S1R.F.
Which industry does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd industry is Medical Distribution.
How many shares does Shanghai Pharmaceuticals Holding Co., Ltd have in circulation?
The max supply of Shanghai Pharmaceuticals Holding Co., Ltd shares is 5.84B.
What is Shanghai Pharmaceuticals Holding Co., Ltd Price to Earnings Ratio (PE Ratio)?
Shanghai Pharmaceuticals Holding Co., Ltd PE Ratio is 10.23077000 now.
What was Shanghai Pharmaceuticals Holding Co., Ltd earnings per share over the trailing 12 months (TTM)?
Shanghai Pharmaceuticals Holding Co., Ltd EPS is 0.13 EUR over the trailing 12 months.
Which sector does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd sector is Healthcare.